BROOK LANE PSYCHIATRIC CENTER
1. Target Overview & Investment Thesis
BROOK LANE PSYCHIATRIC CENTER is a 65-bed safety-net/medicaid heavy in WASHINGTON, MD with $26.6M in net patient revenue and a 0.4% operating margin. The hospital serves a payer mix of 5.9% Medicare, 53.3% Medicaid, and 40.8% commercial.
Thesis: Turnaround. Our ML models identify $2.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 0.4% to 7.7% (+736bps).
| Net Revenue HCRIS | $26.6M |
| Current EBITDA COMPUTED | $97K |
| Operating Margin COMPUTED | 0.4% |
| Occupancy HCRIS | 74.6% |
| Revenue / Bed COMPUTED | $409K |
| Net-to-Gross HCRIS | 83.2% |
| Distress Probability ML | 60.6% |
2. Market Context & Competitive Position
MD has 59 Medicare-certified hospitals with a median operating margin of -8.3%. The target's margin of 0.4% places it above the state median. Among 17 size-comparable peers (32-130 beds), the median margin is -4.6%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (32-130), prioritizing same-state peers. 17 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| BROOK LANE PSYCHIATRIC CENTER (Target) | MD | 65 | $26.6M | 0.4% |
| KENNEDY KRIEGER | MD | 50 | $203.5M | -50.0% |
| ST. MARYS HOSPITAL | MD | 105 | $198.5M | -1.5% |
| UNION HOSPITAL OF CECIL COUNTY | MD | 124 | $184.1M | -4.6% |
| MEDSTAR MONTGOMERY MEDICAL CEN | MD | 96 | $173.7M | -14.1% |
| CIVISTA MEDICAL CENTER | MD | 98 | $154.9M | 2.9% |
| CALVERT MEMORIAL HOSPITAL | MD | 78 | $150.0M | -7.2% |
| ATLANTIC GENERAL HOSPITAL | MD | 62 | $148.6M | -12.0% |
| HOLY CROSS GERMANTOWN HOSPITAL | MD | 78 | $127.2M | -29.6% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.0M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $558K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $531K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $526K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $323K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $17K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $97K |
| + RCM Uplift | +$2.0M |
| Pro Forma EBITDA | $2.1M |
| Current Margin | 0.4% |
| Pro Forma Margin | 7.7% |
| WC Released (1x) | $1.0M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $150K | $20.2M | 134.91x | 166.7% |
| Base (11x exit) | 10.0x | 11.0x | $150K | $22.3M | 148.73x | 171.9% |
| Bull Case | 9.0x | 11.0x | $135K | $28.8M | 213.51x | 192.3% |
| Bull (12x exit) | 9.0x | 12.0x | $135K | $31.4M | 233.22x | 197.6% |
| Bear Case | 11.0x | 10.0x | $165K | $10.4M | 62.98x | 129.0% |
| Bear (11x exit) | 11.0x | 11.0x | $165K | $11.5M | 69.60x | 133.6% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Elevated Medicaid exposure (53.3%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
| High | Elevated distress probability | Model estimates 60.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 17 hospitals with 32-130 beds
- Same-state prioritization (n=18)
- Comp margins: P25=-14.1% / P50=-4.6% / P75=2.9%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.